Suchergebnisse - "Clairmont, Caroline"

PubPharm (21)

1

A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer

enthalten in: Investigational new drugs | 2005

von Murren, J. | Modiano, M. | Kummar, S. | +4

2

A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer

enthalten in: Investigational new drugs | 2005

von Murren, J. | Modiano, M. | Kummar, S. | +4

3

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

enthalten in: Cancer chemotherapy and pharmacology | 2004

von Yen, Y. | Margolin, K. | Doroshow, J. | +5

4

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

enthalten in: Cancer chemotherapy and pharmacology | 2004

von Yen, Y. | Margolin, K. | Doroshow, J. | +5

5

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

enthalten in: Cancer chemotherapy and pharmacology | 2004

von Yen, Y. | Margolin, K. | Doroshow, J. | +5

6

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

enthalten in: Cancer chemotherapy and pharmacology | 2004

von Yen, Y. | Margolin, K. | Doroshow, J. | +5

7

Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2004

von Wadler, S. | Makower, D. | Clairmont, C. | +3

8

A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2004

von Giles, F. | Thomas, D. | Garcia-Manero, G. | +12

9

PHASE I AND CLINICAL PHARMACOLOGY - Phase I and Pharmacokinetic Study of the Ribonucleotide Reductase Inhibitor, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, Administered by 96-Hour Intravenous Continuous Infusion

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2004

von Wadler, S. | Makower, D. | Clairmont, C. | +3

10

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

enthalten in: Cancer gene therapy | 2003

von Nemunaitis, J. | Cunningham, C. | Senzer, N. | +7